The Global Market for Needle-Free Drug Injection Systems is Projected to Cross US$4 Billion by 2022

Economic & Social Burden of Blood Borne Diseases Associated With Unsafe Injection Practices Drives the Global Market for Needle-Free Drug Injection Systems Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches a comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Needle-Free Drug Injection Systems market. The global market for Needle-Free Drug Injection Systems is projected to cross US$4 billion by 2022, driven by the economic and social burden of blood borne diseases associated with needlestick injuries, poor syringe hygiene and unsafe injection practices and the ensuing search for safer, pain-free drug injection alternatives. 

Needle-free drug injection systems are novel methods of introducing different types of medicines into a human body without piercing one’s skin, as is the case with conventional needles. This drug delivery system works on the principle of forcing liquid formulation into the human body at a rapid pace through a small opening which is held against patient’s skin. Compared to conventional syringes, needle-free injection devices not only give the user freedom from unwarranted pain, but can also be used for administering drugs in solid pallet form. Needle-free drug injection systems cover a wide range of drug delivery mechanisms, which administer drugs into a human body through intradermal route and can include any method such as electrophoresis, Lorentz, pressure by gas or shock waves, virtually making needle redundant.

Needle-Free Drug Injection Systems present a win-win situation for both pharmaceutical industry as well as the developing world, since the technology is convenient for mass immunization programs, and reduces needlestick injuries. Moreover, use of needle-free injection systems is expected to augment the rate of vaccinations. Needle-free drug injection devices are developed keeping in mind a patient’s requirements for home-use and self-administration of drugs for diseases, both lifestyle and age-related. Patients, especially diabetics find it stressful to take daily doses of insulin and hence are seeking cost-effective, pain-free, safer and easier to handle innovative drug delivery technologies. Major growth drivers of the market include increasing prevalence of chronic diseases, growing incidences of blood borne disease, caused mainly on account of needlestick injuries, growing demand for vaccinations and biosimilars, increasing demand for self-injection devices as well as various advantages of needle-free drug delivery technology. However, the higher development costs incurred while developing these systems might have a negative impact on market growth.

As stated by the new market research report on Needle-Free Drug Injection Systems, the United States represents the largest market worldwide, supported by the growing demand for self-injection devices against the backdrop of increasing incidence of chronic diseases such as arthritis, cancer, heart disease, obesity, stroke, and type-2 diabetes, among others and the growing preference for self-care. Asia-Pacific is poised to grow at the fastest CAGR of over 12.8% through the analysis period driven by growing population and a parallel increase in healthcare burden; relatively underdeveloped healthcare services infrastructure in developing Asian countries and risk of blood borne diseases higher than the global average due to improper needle use and hygiene; focus on alternative care settings that requires home-based, needle-free drug delivery systems; rising healthcare spending in countries such as China and India; growing trend of medical tourism and the need to achieve the highest standards in safety and quality of healthcare care services.

Major players in the market include AKRA Dermojet, Crossject SA, D’Antonio Consultants International Inc., Medical International Technologies Inc., National Medical Products Inc., and PharmaJet, Zogenix Inc.

The research report titled "Needle-Free Drug Injection Systems: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific, Latin America, and Rest of World.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.